Kreutzfeldt, S., Apostolidis, L., Oles, M., Horak, P., Heilig, C. E., Heining, C., . . . Fröhling, S. (2019). 18P Clinical outcome of personalised treatment guided by genome and transcriptome sequencing in patients with neuroendocrine neoplasms: Updated results from the German NCT/DKTK MASTER trial. Annals of Oncology, 30, N.PAG. https://doi.org/10.1093/annonc/mdz413.023
Chicago Style (17th ed.) CitationKreutzfeldt, S., et al. "18P Clinical Outcome of Personalised Treatment Guided by Genome and Transcriptome Sequencing in Patients with Neuroendocrine Neoplasms: Updated Results from the German NCT/DKTK MASTER Trial." Annals of Oncology 30 (2019): N.PAG. https://doi.org/10.1093/annonc/mdz413.023.
MLA (9th ed.) CitationKreutzfeldt, S., et al. "18P Clinical Outcome of Personalised Treatment Guided by Genome and Transcriptome Sequencing in Patients with Neuroendocrine Neoplasms: Updated Results from the German NCT/DKTK MASTER Trial." Annals of Oncology, vol. 30, 2019, p. N.PAG, https://doi.org/10.1093/annonc/mdz413.023.